Sigma® Life Science to Supply Oligonucleotides to Research Councils UK
News Sep 20, 2010
Sigma® Life Science, a division of Sigma-Aldrich® Corporation and a European manufacturer of oligonucleotides, has signed a three-year contract with Research Councils UK (RCUK) Shared Services Centre Limited to be a preferred supplier for synthetic oligonucleotides.
With more than 20 years of experience in oligonucleotide synthesis, Sigma Life Science offers a broad commercially available range of high quality oligonucleotide modifications, purifications, synthesis scales and qPCR probes.
Michael Harris, Managing Director of Europe, Middle East, Africa regions for Sigma-Aldrich, commented: “Sigma Life Science has been a preferred oligonucleotide supplier to the Medical Research Council (one of the UK’s seven Research Councils) for over four years, and we are delighted that the quality of our products and service has resulted in the expansion of this contract. This new agreement is expected to enable additional RCUK researchers to access Sigma’s products, as well as allow Sigma Life Science to consolidate its relationship with RCUK.”
Sigma Life Science provides a wide range of other molecular biology reagents, including nucleic acid amplification and purification reagents, RNAi products (including shRNA, siRNA and the innovative ZFN technology) and more than 38,000 antibodies.